ZEALAND PHARMA - 2026 FINANCIAL GUIDANCE FOR COLLABORATION REVENUE, OPERATING EXPENSES UNCHANGED, TO BE DKK 4.5 BLN AND DKK 2.7-3.3 BLN, RESPECTIVELY

Reuters · 3d ago

Please log in to view news